Keloid Clinical Trial
Official title:
Evaluation of Fractional CO2 and Non Ablative Long Pulsed Nd YAG Lasers Alone and in Combination in Treatment of Keloids
clinical comparative study comparing the effectiveness of fractional CO2, long pulsed Nd YAG and their combination in collagen remodeling in keloid clinically, biochemically and histopathologically
Patients The study included 30 Egyptian patients with keloid scar recruited from the Out
Patient Clinic, Dermatology Department, Cairo University.
Methodology
Patients:
- Thirty patients with keloid scar(s) were included in the study
- Every patient was subjected to the following:
1. Complete history taking: History of disease onset, course and duration, family history
as well as history of any systemic or dermatological disease interfering with the
eligibility of participation in the study.
Thirty patients were included in the study which is a clinical comparative study
comparing the effectiveness of fractional CO2, long pulsed Nd YAG and their combination
in collagen remodeling in keloid clinically in all the included patients and
biochemically and immunohistochemically fifteen patient
2. Full clinical examination:
- General examination to determine any systemic or dermatological disease that might
preclude the patient from participation in the study such as collagen disease.
- Local examination to determine Fitzpatrick skin color of the patient and the site
and extent of the scar to be treated.
Methods:
- Cases with multiple keloid scars three lesions 2 to 3 cm apart from each other were
selected and labeled. The first one (lesion A) was treated using fractional CO2 laser
10,600 nm, the second (lesion B) long pulsed Nd YAG laser 1064 nm, while the last
(lesion C) combined fractional CO2 followed by Nd YAG lasers after half an hour were
used
- patients who had a large sized lesion, the lesion was divided into three equal parts 2
to 3 cm apart from each other, they were labeled as areas A, B and C then subjected to
the same treatment modalities as mentioned in case of multiple lesions.
- Patients received 4 treatment sessions 4 to 8 weeks apart. Laser modalities and
parameters
- Topical anesthesia (lidocaine 2.5% and prilocaine 2.5%) was applied to the working
area 30 to 60 minutes before the sessions, washed off and properly dried before the
procedure.
- Ablative fractional 10,600 nm carbon dioxide laser (DEKA smartxide DOT, Italy) and
long pulsed Nd-YAG (DEKA synchro FT) were used in the treatment sessions with the
following parameters Fractional CO2 Stacking: 5, Power: 20 Watt, Dwell time: 1000
micro second, Spacing : 800 micro meter fluence: 40 j/cm2 Pulse duration: 0.3 milli
second Spot size: 5 mm Passes: 3.
Assessment Assessment was done before treatment every session and one months after the
final laser treatment. Clinical assessment was done for all patients while
histopathological and biochemical assessment were done only in 15 patients.
A. Clinical evaluation Clinical assessment was fulfilled via calculating the scores of
both the Vancouver Scar Scale; and the Patient and Observer Scar Assessment Scale.
Patients were assessed every session, any side effects were reported, e.g pain,
swelling, infection, hyper pigmentation or hypo pigmentation.
B. Histopathological and biochemical evaluation
Fifteen patients were randomly selected and subjected to the pre and post treatment
biopsies :
- Pretreatment biopsy:
Three mm punch skin biopsy was taken from the keloid (any lesion A, B, or C) before
starting treatment sessions ●Post treatment biopsies: Each lesion (A, B, C) was biopsied
separately (3 mm punch biopsy), one month after last treatment session.
Biopsies of controls ●parts of excess skin from 12 patients undergoing abdominoplasty
were used as controls for levels of TGFβ1 and TGFβ3.
Procedure
- Biopsies were fixed in 10 % neutral buffered formalin, and then embedded in paraffin
blocks. Sections were prepared for routine staining by H&E. Other sections were prepared
for histochemical staining of collagen fibres using Masson's trichrome stain and elastic
fibres using orcein stain
- All sections were examined using a Zeiss, Primo star light microscope (Zeiss,
Germany). The microscope has an integrated camera by which photomicrographs depicting
the various histopathological and histochemical findings were obtained. All
photomicrographs presented in the thesis are according to their original magnification.
• Evaluation of elastic fibres in orcein stained sections:
Orcein stained sections were graded according to the grading criteria proved by Ozog et
al. in 2013 for the appearance of the dermal elastic tissue as follows:
0 normal
1. short fragmented elastic fibres
2. intermediate between 1 and 3
3. fibrillar elastic fibres, parallel to epidermis
4. intermediate between 3 and 5
5. absent or nearly absent.
Image analyzer evaluation (morphometric study):
The area percent of collagen and elastic fibres were quantitatively evaluated in Masson's
trichrome and orcein stained sections respectively at magnification X100 in 5 non overlapping
fields for all patients. Image analysis was done using Leica Qwin 500C image analyzer
computer system (England) present in the Histology Department, Faculty of Medicine, Cairo
University .
;
Status | Clinical Trial | Phase | |
---|---|---|---|
Recruiting |
NCT02923596 -
Retrospective Study of Keloid Disorder
|
N/A | |
Completed |
NCT02922972 -
Treatment of Keloid Scar by Autologous Platelet Rich Plasma Obtained With RgenKit-BCT
|
N/A | |
Terminated |
NCT01478243 -
Study of Psycho-Social Impact of Keloid
|
N/A | |
Recruiting |
NCT01423383 -
Epidemiology Study of Keloid
|
N/A | |
Completed |
NCT03228693 -
Gene Expression and Biomarker Profiling of Keloid Skin
|
N/A | |
Not yet recruiting |
NCT04326959 -
Implantation of Mesenchymal Stem Cell, Conditioned Medium, or Triamcinolone Acetonide for Keloid
|
Phase 1/Phase 2 | |
Recruiting |
NCT03312166 -
Compressive Device to Prevent Keloïd Scars Recurrence [SCARWARS]
|
N/A | |
Recruiting |
NCT02823236 -
Efficacy of Intralesional Triamcinolone and 8% Topical Pirfenidone for Treatment of Keloid Scars
|
Phase 3 | |
Recruiting |
NCT04597060 -
The Safety and Efficacy of Thermo-mechanical System for Fractional Ablation Associated Triamcinolone Acetonide Drug Delivery for the Treatment of Hypertrophic Scars and Keloids
|
N/A | |
Completed |
NCT05939817 -
The Effect of Intralesian Injection of Umbilical Cord Mesenchymal Stem Cells, Its Conditioned Medium, and Triamcinolone Acetonide on Type 1:3 Collagen Ratio and Interleukin-10 Levels in Keloid: A Randomised Controlled Trial
|
Phase 4 | |
Completed |
NCT05887804 -
Comparison of Keloid Volume and Symptoms Reduction Between Intralesional Umbilical-Cord Mesenchymal Stem Cells, Its Conditioned Medium, and Triamcinolone Acetonide Injection as Keloid Therapy: A Randomised Controlled Trial
|
Phase 4 | |
Completed |
NCT03630198 -
Pain Outcomes Following Intralesional Corticosteroid Injections
|
Phase 4 | |
Completed |
NCT04169438 -
Pilot Study Investigating a Restorative Wound Care Cream Together With Petrolatum on Surgical Excisions
|
N/A | |
Recruiting |
NCT01423981 -
Web Based Investigation of Natural History of Keloid Disorder, an Online Survey
|
N/A | |
Completed |
NCT01446770 -
Evaluation of the Initial Safety and Efficacy of Keloid Lesions Treated With MF-4181
|
Phase 2 | |
Recruiting |
NCT06138964 -
Comparing the Effect of siSPARC Microneedle Patch Versus siSPARC+siLR4A Microneedle Patch on Post-surgical Scars
|
Phase 3 | |
Enrolling by invitation |
NCT05461157 -
Preoperative Silicone Ointment and Wound Healing
|
N/A | |
Not yet recruiting |
NCT04593706 -
Comparison of the Efficacy of Different Steroids in the Treatment of Abnormal Scars (Keloids, Hypertrophic Scars)
|
N/A | |
Active, not recruiting |
NCT04988022 -
Dupilumab in the Treatment of Keloids
|
Phase 4 | |
Withdrawn |
NCT02546076 -
Comparison of Dual-mode ER:YAG Laser in Patients With Long Keloid/Hypertrophic Scars
|
Phase 2 |